Skip to main content
Purple Biotech Ltd. logo

Purple Biotech Ltd. — Investor Relations & Filings

Ticker · PPBT ISIN · IL0007650166 TA Manufacturing
Open in API
Filings indexed 1,071 across all filing types
Latest filing 2025-04-22 AGM Information
Country IL Israel
Listing TA PPBT

About Purple Biotech Ltd.

https://purple-biotech.com/

Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.

Recent filings

Filing Released Lang Actions
6K:Purple Biotech announcing the results of the Annual General Meeting of Shareholders of the Company held on April 22, 2025
AGM Information Classification · 98% confidence The document is explicitly titled "FORM 6-K" and is a "Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934". The content details the results of the Annual General Meeting (AGM) of Shareholders held on April 22, 2025, including the approval/rejection of director re-elections and capital structure changes. Since the document reports the *results* of the shareholder vote at the AGM, it directly corresponds to the Declaration of Voting Results & Voting Rights Announcements category (DVA). Although it relates to an AGM, the primary function here is reporting the outcome of the vote, not providing the presentation materials (AGM-R) or the proxy solicitation (PSI).
2025-04-22 English
6K:Purple Biotech announcing the results of the Annual General Meeting of Shareholders of the Company held on April 22, 2025
AGM Information Classification · 98% confidence The document explicitly states it is a '6K:Purple Biotech announcing the results of the Annual General Meeting of Shareholders of the Company held on April 22, 2025'. The content is an immediate report filed with the Israel Securities Authority and the Tel Aviv Stock Exchange, referencing the results of an AGM. Since the document is short (2230 chars) and primarily serves to announce the results of the AGM and points to an attached PDF ('ea023911201-6k_purpleEDGAR1_Bannerless_isa.pdf'), it fits the description of an announcement regarding meeting results rather than the full AGM presentation itself. The most specific category for official results from a shareholder vote is 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it relates to an AGM, DVA is more precise than AGM-R (which is for presentations/materials). Given the context of reporting results, DVA is the best fit.
2025-04-22 English
Publication in the Neuro Oncology Journal Demonstrating the Potential of NT219 to Suppress Brain Metastasis of Colorectal Cancer
Regulatory Filings Classification · 99% confidence The document is explicitly titled 'FORM 6-K' and is filed by a 'Foreign Private Issuer' with the SEC. Form 6-K is used to report material information that a foreign private issuer is required to disclose to its home country's securities regulator or stock exchange, or that it makes public in its home country. The content is a press release announcing the publication of scientific findings regarding their drug NT219 in the journal *Neuro Oncology*. This type of announcement, which disseminates material, non-public information outside of the regular periodic reports (like 10-K or IR), is typically filed on Form 6-K. Since the provided definitions do not have a specific code for Form 6-K, and this document is a general regulatory disclosure announcing corporate news (a press release), the most appropriate fallback category is 'Regulatory Filings' (RNS), as it serves as a general catch-all for required regulatory disclosures that don't fit the highly specific categories like ER, DIV, or DIRS. The document is not short enough to be a simple RPA, as it contains the full text of the press release and extensive legal boilerplate/incorporation by reference.
2025-04-16 English
Publication in the Neuro Oncology Journal Demonstrating the Potential of NT219 to Suppress Brain Metastasis of Colorectal Cancer
Report Publication Announcement Classification · 98% confidence The document is very short (2270 characters) and explicitly states that it is an 'Immediate Report' under Regulation 4, referencing an attached PDF file ('ea023850901-6k_purpleEDGAR1_Bannerless_isa.pdf'). The title indicates an announcement regarding a publication in a journal. According to Rule 2 (The 'MENU VS MEAL' Rule), when a document is short and announces that a report is attached or published, it should be classified as a Report Publication Announcement (RPA) rather than the underlying report itself. Although it mentions '6K', which is an SEC filing type, the context here is an announcement of that filing/information being made public via the Israeli regulatory system (ISA/TASE). Therefore, RPA is the most appropriate classification for this announcement wrapper.
2025-04-16 English
Annual General Meeting will be held on the day Tuesday on the date : 22/04/2025 time: 16:30
AGM Information Classification · 98% confidence The document is explicitly titled 'VOTING SLIP FOR ANNUAL GENERAL MEETING OF SHAREHOLDERS'. It contains specific details about the Meeting date (April 15, 2025), the type of meeting (Annual General Meeting), and lists specific proposals (re-election of directors, approval of equity awards, capital increase) that shareholders are asked to vote on using this slip. This material is directly related to soliciting or recording votes for the AGM, which aligns perfectly with the definition of AGM Information (AGM-R) or potentially Proxy Solicitation & Information Statement (PSI). Since this is the actual voting slip/form used at or for the AGM, AGM-R is the most precise classification for materials directly pertaining to the Annual General Meeting process and voting.
2025-04-15 English
Annual General Meeting will be held on the day Tuesday on the date : 22/04/2025 time: 16:30
AGM Information Classification · 98% confidence The document is explicitly titled "FORM 6-K" and is filed by a Foreign Private Issuer. The core content announces that an "Annual General Meeting of Shareholders" will be held on April 15, 2025, and states that the "Notice of Annual General Meeting of Shareholders and the Proxy Statement" are attached as exhibits. The document itself is the Form 6-K filing that contains the announcement and the attached proxy materials. Since the primary purpose of the filing is to announce the details and materials for the upcoming Annual General Meeting (AGM), the most specific classification is AGM-R (AGM Information). Although it is filed on a Form 6-K, the content dictates the functional classification. It is not a DEF 14A (which is typically a US proxy statement) but rather the announcement of the AGM and its associated documents, fitting best under AGM-R.
2025-04-15 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.